Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Karim Mikhail. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
59%
Total
Publications
5.5K
Total Open
Publications
3.3K
Total
Citations
287K
Open Access
Percentage
59%
Total
Publications
5.5K
Total Open
Publications
3.3K
Total
Citations
287K
Breakdown
Publisher Open
16%
Both
35%
Other Platform Open
9%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 57%
1.6K
Hybrid 15%
437
No Guarantees 28%
789
Other Platform Open
Domain 85%
2.1K
Institution 43%
1.1K
Other Internet 8%
191
Preprint 6%
143
Public 5%
122
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.1K |
doaj.org OAI-PMH Repository | Institution | 720 |
DOI | Other Internet | 175 |
Office of Scientific and Technical Information | Institution | 159 |
Figshare | Public | 113 |
bioRxiv | Preprint | 95 |
Europe PMC | Domain | 74 |
National Institutes of Health | Institution | 41 |
Unknown Repository | Other Internet | 39 |
medRxiv | Preprint | 34 |